T. Rowe Price Associates’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Buy |
|
|||||
|
2025
Q1 | $184K | Buy |
|
|||||
|
2024
Q4 | $387K | Buy |
|
|||||
|
2024
Q3 | $523K | Buy |
|
|||||
|
2024
Q2 | $443K | Sell |
|
|||||
|
2024
Q1 | $639K | Buy |
|
|||||
|
2023
Q4 | $459K | Sell |
|
|||||
|
2023
Q3 | $862K | Sell |
|
|||||
|
2023
Q2 | $12.1M | Buy |
|
|||||
|
2023
Q1 | $13.7M | Buy |
|
|||||
|
2022
Q4 | $13.9M | Sell |
|
|||||
|
2022
Q3 | $33.2M | Sell |
|
|||||
|
2022
Q2 | $46.8M | Sell |
|
|||||
|
2022
Q1 | $72.3M | Buy |
|
|||||
|
2021
Q4 | $81.6M | Buy |
|
|||||
|
2021
Q3 | $75M | Buy |
|
|||||
|
2021
Q2 | $35.6M | Buy |
|
|||||
|
2021
Q1 | $11.9M | Buy |
|